Skip to main content
Year archive

SK Bioscience Co.,Ltd — 2025 filings

All 48 regulatory filings released by SK Bioscience Co.,Ltd (302440) in 2025, sourced directly from the official regulator.

48 Filings
2025 Period
2025 filings (48)
Filing Released Lang
[기재정정]신규시설투자등
Capital/Financing Update
2025-12-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2025-12-26 Korean
최대주주등소유주식변동신고서
Director's Dealing
2025-12-26 Korean
[기재정정]단일판매ㆍ공급계약체결
Capital/Financing Update
2025-12-23 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Regulatory Filings
2025-11-03 Korean
기업설명회(IR)개최(안내공시)
Regulatory Filings
2025-11-03 Korean
기업설명회(IR)개최(안내공시)
Regulatory Filings
2025-10-23 Korean
기타안내사항(안내공시)
Regulatory Filings
2025-10-17 Korean
임원ㆍ주요주주특정증권등거래계획보고서
Major Shareholding Notification
2025-09-19 Korean
특수관계인에대한부동산매도
Regulatory Filings
2025-09-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-09-19 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Governance Information
2025-08-29 Korean
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Regulatory Filings
2025-08-13 Korean
반기보고서 (2025.06)
Interim / Quarterly Report H1 2025
2025-08-12 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q2 2025
2025-07-31 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2025-07-31 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2025-07-21 Korean
[기재정정]타법인주식및출자증권취득결정(종속회사의주요경영사항)
M&A Activity
2025-06-25 Korean
[기재정정]투자판단관련주요경영사항 (21가 폐렴구균백신(GBP410)의 미국 제3상 임상시험계획 (IND) 승인)
Legal Proceedings Report
2025-06-09 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2025-06-04 Korean
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Major Shareholding Notification
2025-05-30 Korean
기업지배구조보고서공시
Governance Information
2025-05-30 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Q1 2025
2025-05-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2025
2025-05-07 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2025-05-07 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2025-04-22 Korean
[기재정정]투자판단관련주요경영사항 (21가 폐렴구균백신(GBP410)의 미국 제3상 임상시험계획 (IND) 신청)
Regulatory Filings
2025-04-08 Korean
[기재정정]투자판단관련주요경영사항 (21가 폐렴구균백신(GBP410)의 유럽 제3상 임상시험계획 (CTA) 승인 (Part I, Part II))
Regulatory Filings
2025-04-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2025-03-28 Korean
투자판단관련주요경영사항 (21가 폐렴구균백신(GBP410)의 유럽 제3상 임상시험계획 (CTA) 승인 (Part I, Part II))
Regulatory Filings
2025-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2025-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2025-03-26 Korean
감사보고서제출
Audit Report / Information FY 2024
2025-03-17 Korean
사업보고서 (2024.12)
Audit Report / Information FY 2024
2025-03-17 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings
2025-02-28 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2025-02-25 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2025-02-25 Korean
주주총회소집결의
AGM Information
2025-02-25 Korean
[기재정정]투자판단관련주요경영사항 (21가 폐렴구균백신(GBP410)의 미국 제3상 임상시험계획 (IND) 신청)
Legal Proceedings Report
2025-02-18 Korean
[기재정정]투자판단관련주요경영사항 (21가 폐렴구균백신(GBP410)의 미국 제3상 임상시험계획 (IND) 승인)
Legal Proceedings Report
2025-02-18 Korean
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Regulatory Filings
2025-02-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2024
2025-02-05 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q4 2024
2025-02-05 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2025-02-05 Korean
결산실적공시예고(안내공시)
Report Publication Announcement
2025-01-23 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2025-01-23 Korean
투자판단관련주요경영사항 (21가 폐렴구균백신(GBP410)의 미국 제3상 임상시험계획 (IND) 승인)
Regulatory Filings
2025-01-17 Korean
투자판단관련주요경영사항 (21가 폐렴구균백신(GBP410)의 한국 제3상 임상시험계획 (IND) 승인)
Regulatory Filings
2025-01-14 Korean